No CrossRef data available.
Article contents
Zopiclone in the treatment of insomnia in depressed patients
Published online by Cambridge University Press: 16 April 2020
Summary
During the early treatment of a major depressive episode with amitryptiline, insomnia was treated in 81 patients in a double-blind comparative trial comparing zopiclone and flunitrazepam. The study showed no major differences in the efficacy profile and showed better tolerability for zopiclone than for flunitrazepam.
- Type
- Research Article
- Information
- European Psychiatry , Volume 10 , Issue S3: Satellite Symposium to the AEP Congress , 1995 , pp. 167s - 172s
- Copyright
- Copyright © Elsevier, Paris 1995
References
Dominguez, RAJacobson, AFGoldstein, BJSteinbok, RMComparison of triazolam and placebo in the treatment of insomnia in depressed patients. Curr Ther Res 1984; 36: 856–65Google Scholar
Fleming, JAEThe difficulty to treat insomniac patients. J Psychosomatic Res 1993; 37(suppl 1):45–54CrossRefGoogle Scholar
Pringuey, DFeuillade, PhBelugou, JLTonelli, IRobert, PHDarcourt, GSommeil, rythmes biologiques et dépression. Neuro-Psy septembre 1991; 6: 382–93Google Scholar
Reynolds, CFKupfer, DJSleep research in affective illness: state of the art. Sleep 1987; 10: 199–215CrossRefGoogle ScholarPubMed
Spiegel, RControlled clinical investigations with a phenothiazine derivative used as sleep-inducer in non-psychotic insomniacsSleep: Physiology, Biochemistry, Psychology, Pharmacology, Clinical Implications 1 st European Congress, Sleep Res Basel: Karger, 1972 91–101Google Scholar
Comments
No Comments have been published for this article.